Trial Profile
Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Thromboembolism; Thrombosis
- Focus Therapeutic Use
- 10 Jun 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov record.
- 04 Feb 2013 New trial record